Pancreatic Cancer Research

ResearcherThe University of Texas at San Antonio Health Science CenterActive in the last 2 years

Chen Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9317-9588; OpenAlex author ID A5030309368. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2022: 2 papers · 2023: none · 2024: 1 paper

Papers 3

  1. Long non-coding RNAs and tyrosine kinase-mediated drug resistance in pancreatic cancer. Last author DOI 10.1016/j.gene.2023.148007↗
  2. Gemcitabine resistance of pancreatic cancer cells is mediated by IGF1R dependent upregulation of CD44 expression and isoform switching. Co-author DOI 10.1038/s41419-022-05103-1↗
  3. GABRP promotes CD44s-mediated gemcitabine resistance in pancreatic cancer. Co-author DOI 10.7717/peerj.12728↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jin‐Song Shi · 2 shared papers, 2022–2024 · strength 0.41
  2. Dangran Li · 1 shared paper, 2024 · strength 0.23
  3. James W. Freeman · 1 shared paper, 2022 · strength 0.17
  4. Addanki Pratap Kumar · 1 shared paper, 2022 · strength 0.17
  5. Shujie Zhao · 1 shared paper, 2022 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.